Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Myasthenia Gravis (gMG)”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Looking for participantsNCT06987539
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

Who this might be right for
Generalized Myasthenia Gravis
Amgen 15
Testing effectiveness (Phase 2)Looking for participantsNCT07284420
What this trial is testing

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Who this might be right for
AChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia GravisMG+3 more
argenx 70
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Not applicableLooking for participantsNCT07411963
What this trial is testing

Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis

Who this might be right for
Myasthenia Gravis
Centre Hospitalier Universitaire de Nice 30
Large-scale testing (Phase 3)Study completedNCT04124965
What this trial is testing

Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 71
Post-approval studies (Phase 4)Looking for participantsNCT07246564
What this trial is testing

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
UCB Biopharma SRL 40
Large-scale testing (Phase 3)Looking for participantsNCT06456580
What this trial is testing

Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Who this might be right for
Generalized Myasthenia Gravis
Vor Biopharma 180
Large-scale testing (Phase 3)Looking for participantsNCT06607627
What this trial is testing

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Study completedNCT06764160
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG

Who this might be right for
Generalized Myasthenia Gravis (gMG)Refractory gMG
Alexion Pharmaceuticals, Inc. 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05556096
What this trial is testing

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 261
Large-scale testing (Phase 3)Study completedNCT03759366
What this trial is testing

Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Who this might be right for
Myasthenia GravisMyasthenia Gravis, Juvenile FormMyasthenia Gravis, Generalized
Alexion Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Looking for participantsNCT07215949
What this trial is testing

Zilucoplan for Severe gMG Exacerbations

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Miriam Freimer 15
Not applicableLooking for participantsNCT04202341
What this trial is testing

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 500
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT06359041
What this trial is testing

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Cabaletta Bio 12
Large-scale testing (Phase 3)Enrolling By InvitationNCT06540144
What this trial is testing

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05403541
What this trial is testing

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Immunovant Sciences GmbH 240
Early research (Phase 1)Looking for participantsNCT07215650
What this trial is testing

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

Who this might be right for
Generalized Myasthenia Gravis
Candid Therapeutics 44
Not applicableLooking for participantsNCT07294170
What this trial is testing

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Who this might be right for
Myasthenia GravisMGgMG+3 more
argenx 70
Testing effectiveness (Phase 2)Ended earlyNCT05218096
What this trial is testing

Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisMyasthenia Gravis
Alexion Pharmaceuticals, Inc. 70
Load More Results